Richter, A.; Fischer, E.; Holz, C.; Schulze, J.; Lange, S.; Sekora, A.; Knuebel, G.; Henze, L.; Roolf, C.; Murua Escobar, H.;
et al. Combined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia. Int. J. Mol. Sci. 2021, 22, 2771.
https://doi.org/10.3390/ijms22052771
AMA Style
Richter A, Fischer E, Holz C, Schulze J, Lange S, Sekora A, Knuebel G, Henze L, Roolf C, Murua Escobar H,
et al. Combined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences. 2021; 22(5):2771.
https://doi.org/10.3390/ijms22052771
Chicago/Turabian Style
Richter, Anna, Elisabeth Fischer, Clemens Holz, Julia Schulze, Sandra Lange, Anett Sekora, Gudrun Knuebel, Larissa Henze, Catrin Roolf, Hugo Murua Escobar,
and et al. 2021. "Combined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia" International Journal of Molecular Sciences 22, no. 5: 2771.
https://doi.org/10.3390/ijms22052771
APA Style
Richter, A., Fischer, E., Holz, C., Schulze, J., Lange, S., Sekora, A., Knuebel, G., Henze, L., Roolf, C., Murua Escobar, H., & Junghanss, C.
(2021). Combined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia. International Journal of Molecular Sciences, 22(5), 2771.
https://doi.org/10.3390/ijms22052771